A Comprehensive Multistate Model Analyzing Associations of Various Risk Factors with the Course of Breast Cancer in a Population-Based Cohort of Breast Cancer Cases

American Journal of Epidemiology

Volumn 183, Issue 4, 2016, Pages 325-334

  Eulenburg, Christine ^a   Schroeder, Jennifer ^a   Obi, Nadia ^a   Heinz, Judith ^a   Seibold, Petra ^b   Rudolph, Anja ^b   Chang Claude, Jenny ^b   Flesch Janys, Dieter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

breast cancer; clock forward model; semi Markov model; survival; transition hazard

Indexed keywords

CANCER; CARDIOVASCULAR DISEASE; DISEASE PREVALENCE; ENVIRONMENTAL HAZARD; HEALTH RISK; HORMONE; MEDICAL GEOGRAPHY; MORTALITY RISK; NUMERICAL MODEL; RISK FACTOR; SURVIVAL;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METASTASIS; OVERALL SURVIVAL; PROSPECTIVE STUDY; SECOND CANCER; TUMOR INVASION; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; MIDDLE AGED; RISK FACTOR; THEORETICAL MODEL;

GERMANY;

AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; GERMANY; HUMANS; LIFE STYLE; MAMMOGRAPHY; MIDDLE AGED; MODELS, THEORETICAL; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84959904024     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv163     Document Type: Article

References (34)

1. Hudis CA, Barlow WE, Costantino JP, et al. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol. 2007; 25(15):2127-2132.
2. Nout RA, Fiets WE, Struikmans H, et al. The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer. Breast Cancer Res Treat. 2008;109(3):567-572.
3. Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11(2):91-115.
4. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11): 2389-2430.
5. Hougaard P. Multi-state models: a review. Lifetime Data Anal. 1999;5(3):239-264.
6. Putter H, van der Hage J, de Bock GH, et al. Estimation and prediction in a multi-state model for breast cancer. Biom J. 2006;48(3):366-380.
7. Meira-Machado L, de Uña-Alvarez J, Cadarso-Suárez C, et al. Multi-state models for the analysis of time-to-event data. Stat Methods Med Res. 2009;18(2):195-222.
8. Meier-Hirmer C, Schumacher M. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer. BMC Med Res Methodol. 2013;13:80.
9. Flesch-Janys D, Slanger T, Mutschelknauss E, et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008;123(4):933-941.
10. Vrieling A, Buck K, Heinz J, et al. Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res Treat. 2012;136(1):195-207.
11. Cox DR. Regression models and life tables (with discussion). J R Stat Soc Series B. 1972;34:187-220.
12. Cox DR. Partial likelihood. Biometrika. 1975;62(2):269-276.
13. Andersen PK, Abildstrom SZ, Rosthøj S. Competing risks as a multi-state model. Stat Methods Med Res. 2002;11(2): 203-215.
14. Iacobelli S, Carstensen B. Multiple time scales in multi-state models. Stat Med. 2013;32(30):5315-5327.
15. Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika. 1981; 68(2):373-379.
16. Klein JP, Szydlo RM, Craddock C, et al. Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate model. Stat Med. 2000; 19(21):3005-3016.
17. Klein JP, Keiding N, Copelan EA. Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients. Stat Med. 1993;12(24):2315-2332.
18. Eulenburg C, Mahner S, Woelber L, et al. A systematic model specification procedure for an illness-death model without recovery. PLoS One. 2015;10(4):e0123489.
19. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
20. R Development Core Team. R: A Language and Environment for Statistical Computing. (Version 3.1.1). Vienna, Austria: R Foundation for Statistical Computing; 2014.
21. de Wreede LC, Fiocco M, Putter H. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed. 2010;99(3):261-274.
22. deWreede LC, Fiocco M, Putter H. mstate: an R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011;38(7):1-30.
23. Therneau TM, Lumley T. survival: Survival Analysis. (Version 2.37-7). Vienna, Austria: Comprehensive R Archive Network; 2014.
24. Stata Corporation. Stata Statistical Software, Release 13. College Station, TX: Stata Corporation; 2013.
25. Schmoor C, Sauerbrei W, Bastert G, et al. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol. 2000;18(8):1696-1708.
26. Fredriksson I, Liljegren G, Arnesson LG, et al. Local recurrence in the breast after conservative surgery-A study of prognosis and prognostic factors in 391 women. Eur J Cancer. 2002; 38(14):1860-1870.
27. Montagna E, Bagnardi V, Rotmensz N, et al. Breast cancer subtypes and outcome after local and regional relapse. Ann Oncol. 2012;23(2):324-331.
28. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006; 24(13):2028-2037.
29. Grann VR, Troxel AB, Zojwalla NJ, et al. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. 2005;103(11):2241-2251.
30. Komoike Y, Akiyama F, Iino Y, et al. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer. 2006;106(1):35-41.
31. Brewster AM, Do KA, Thompson PA, et al. Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol. 2007;25(28):4438-4444.
32. Seibold P, Vrieling A, Heinz J, et al. Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort-differential effects by tumour subtype, NAT2 status, BMI and alcohol intake. Cancer Epidemiol. 2014;38(4): 419-426.
33. Schairer C, Brinton LA. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved. J Natl Cancer Inst. 2013;105(8):513-514.
34. Chlebowski RT, Manson JE, Anderson GL, et al. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. J Natl Cancer Inst. 2013;105(8):526-535.